Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2018.416 | Case control study of non-typhoidal Salmonella infections among children in Hong Kong | Prof. GOGGINS William Bernard |
| 2018.395 | A multicenter evaluation of a combination of nasopharyngeal brush biopsy and plasma for EBV DNA in detecting local failures in nasopharyngeal carcinoma. | Dr. CHAN Jason |
| 2018.386 | Clinical course and biomarkers associated with nonalcoholic fatty liver disease (NAFLD) in Chinese patients with obesity |
Prof. KONG Alice Pik Shan 江碧珊 |
| 2018.379 | A real world study evaluating the safety and efficacy of Prolieve in treating men with symptomatic benign prostatic hyperplasia |
Prof. TEOH Jeremy Yuen Chun 張源津 |
| 2018.387 | A randomized controlled trial of laser treatment in women with stress urinary incontinence |
Dr. CHAN Symphorosa Shing Chee 陳丞智 |
| 2018.391 | Implementation of first-trimester screening and prevention of preeclampsia: a stepped wedge cluster-randomized trial in Asia |
Prof. POON Liona Chiu Yee 潘昭頤 |
| 2018.381 | Cross-sectional study on the association between ambient PM2.5 and TB reactivation |
Dr. LEE Shui Shan 李瑞山 |
| 2018.382 | ILUMIEN IV: OPTIMAL PCI OPtical Coherence Tomography (OCT) Guided Coronary Stent IMplantation Compared to Angiography: a Multicenter Randomized TriaL in PCI |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2018.393 | Validation of a cuffless blood pressure device for 24-hours ambulatory blood pressure monitoring |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2018.394 | The Circulating Cell-free Genome Atlas in Asia (CCGAsia) Study |
Prof. MOK Tony 莫樹錦教授 |
| 2018.392 | A Phase 3, randomized, double-blind clinical study of pembrolizumab (MK-3475) plus chemotherapy versus placebo plus chemotherapy as first-line treatment in participants with HER2 negative, previously untreated, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (KEYNOTE-859) |
Prof. YEO Winnie 楊明明 |
| 2018.372 | NEO-SPACE trial: Neoadjuvant Pembrolizumab-Gemcitabine-Cisplatin followed by Concurrent Pembrolizumab-Chemoradiation and Maintenance Pembrolizumab for Stage IVA Nasopharyngeal Cancer |
Prof. CHAN Anthony Tak Cheung 陳德章 |
| 2018.371 | Tricuspid regurgitation after cardiac implantable electronic device implantation | Dr. TAM Mark Tsz Kin |
| 2018.375 | Prospective Molecular Profiling in Lung Cancer |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2018.400 | Effectiveness of a Modified Dignity Therapy Program on dignity, depression, hope and spiritual well-being among cancer patients undergoing chemotherapy: A randomized control study |
Miss XIAO Jinnan 肖錦南 |
| 2018.377 | Dry Tap During Real-time Ultrasound-guided Paramedian Spinal Injection with Patient in the Lateral Position: A Retrospective Review. |
Prof. KARMAKAR Manoj Kumar 高文佳 |
| 2018.403 | Randomized control trial investigating the effectiveness of vibration therapy on sarcopenia in osteoarthritis knee patients |
Dr. HO Ki Wai 何其威 |
| 2018.383 | Establish a Comprehensive Gut Microbiota Databank and Identify Epidemiological and Health Factors Associated with Gut Microbial Community Profiles in Hong Kong |
Prof. CHAN Paul K.S. 陳基湘 |
| 2018.419 | Detection, localization and assessment of prostate cancer lesions using multi-parametric magnetic resonance imaging | Dr. CHO Carmen |
| 2018.376 | To identify potential new urine markers for the screening of prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2018.405 | Intraoperative Use of Non-invasive Cardiac Output Monitoring versus Standard Fluid Management in Free Perforator Flap Surgery: A Randomized Pilot Trial |
Dr. TAM Suet Yee 談雪儀 |
| 2018.373 | Effect of a family-based lifestyle intervention on the health behaviour of obese or overweight South Asian children in Hong Kong: a cluster-randomised controlled trial |
Prof. SO Winnie K.W. 蘇幗慧 |
| 2018.374 | Mindfulness-based cognitive therapy for grief: a pilot study |
Prof. WONG Samuel Yeung Shan 黃仰山 |
| 2018.370 | Development of a mobile application, ‘MyHealth’, for chronic disease prevention among older people in Hong Kong: a randomised controlled trial |
Dr. TANG Fiona W.K. 鄧穎琪 |
| 2018.368 | Effectiveness of a We-chat based tailored risk communication intervention for increasing colonoscopy uptake among Chinese first-degree relatives of patients with colorectal cancer |
Miss BAI Yang 白杨 |
| 2018.408 | Trauma survival prediction in Asian population: a modification of TRISS to improve accuracy- A 10-year multi-centered review in Hong Kong | Dr. YEUNG Janice Hiu Hung |
| 2018.411 | Deciphering Enhancer Regulation of Tumor Immune Evasion to Develop New Combination Immunotherapies |
Prof. CHENG Alfred Sze Lok 鄭詩樂 |
| 2018.366 | Multicentric observational study on the management of Tuberculosis in the Critical Care setting – Study to Evaluate patient characteristics, predictive scores, management and outcome of Tuberculosis in the Intensive Treatment Unit. Does the route of administration of TB drugs matter in this setting? |
Prof. LUI Grace Chung Yan 雷頌恩 |
| 2018.365 | Do endometrial leucocytes and angiogenesis in the peri-implantation period predict hypertensive disorders in the subsequent pregnancy? | Dr. CHEN Xiaoyan |
| 2018.364 | Association of C-reactive protein (CRP) single nucleotide polymorphism and renal allograft dysfunction in Chinese renal transplant recipients |
Dr. KWONG Vickie Wai Ki 鄺瑋琦 |
| 2018.378 | Comparison of Ultrasound- and Fluoroscopy-Guided Injection for MR Wrist Arthrography in Cadaveric and Clinical patients | Dr. TSOI Carita |
| 2018.380 | Effect of traction in direct, indirect MR arthrography and conventional MRI of hip joints | Dr. TSOI Carita |
| 2018.362 | An open uncontrolled trial of Imagery Rescripting for Depression |
Ms. LEE Sze Wai 李思慧 |
| 2018.363 | A RETROSPECTIVE STUDY ON EFFICACY AND TOLERABILITY OF COMBINATION FLOT CHEMOTHERAPY AS NEOADJUVANT CHEMOTHERAPY IN GASTRIC CANCER PATIENTS |
Prof. YEO Winnie 楊明明 |
| 2018.398 | Evaluation of Energy Harvesting from Human Motions and Gait Health Monitoring Functions of Wearable Devices |
Prof. LIAO Wei Hsin 廖維新 |
| 2018.346 | Co-morbidities, healthcare utilization and survival outcomes of patients with soft-tissue and bone sarcomas in Hong Kong |
Dr. LOONG Herbert Ho Fung 龍浩鋒 |
| 2018.360 | The diagnostic accuracy of using faecal-DNA test (COLOSAFE) for colorectal cancer screening | Mr. LAM Yuen Tung |
| 2018.333 | A Randomized, Multicenter, Double-Blind, Parallel-Group, Active-Control Study of the Efficacy and Safety of Sparsentan for the Treatment of Immunoglobulin A Nephropathy |
Prof SZETO Cheuk Chun 司徒卓俊 |
| 2018.357 | Comprehensive evaluation and mechanism investigation of the PAX4 gene R192H variant on diabetes, diabetes-related traits and diabetic complications |
Prof. MA Ronald 馬青雲 |
| 2018.334 | A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION OF PHASE III STUDIES (BN29552/BN29553) OF CRENEZUMAB IN PATIENTS WITH ALZHEIMER’S DISEASE |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2018.326 | The predictive validity of Functional Independent Measures and Modified Barthel Index on the discharge disposition of older adults after hip surgery: a secondary data analysis |
Dr. AU Brian 區啓明 |
| 2018.342 | Analyzing Patient Flows at the Emergency Department by Data Analytics, Simulation, and Optimization |
Prof. GRAHAM Colin 簡家簾 |
| 2018.351 | FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p | Prof. KANG Wei |
| 2018.345 | Identification of atrial fibrillation patients at risk of intracerebral haemorrhage with advanced retinal imaging (I-SAVE Study) | Prof. LEUNG Thomas |
| 2018.343 | AMOTL1, a crucial member of Motin family, functions as a potential oncogene involved in Hippo-YAP1 signaling to promote gastric tumorigenesis | Prof. KANG Wei |
| 2018.356 | Machine learning versus clinical risk calculator for prostate cancer prediction |
Prof. TEOH Jeremy Yuen Chun 張源津 |
| 2018.336 | European active surveillance of renal cell carcinoma study (EASE RCC Study) |
Dr. WONG Hon Ming 黃翰明 |
| 2018.328 | The immunological link between pattern recognition receptors and the activation of innate lymphoid type 2 cells in allergic inflammation |
Prof. WONG Chun Kwok 黃振國 |
| 2018.335 | EUS – guided balloon-occluded gastrojejunostomy bypass (EPASS) versus uncovered duodenal stent for unresectable malignant gastric outlet obstruction. |
Prof. TEOH Anthony Yuen Bun 張源斌 |
| 2018.352 | Regulation of tumor cell invasion/metastasis and EMT/stemness by a new Ras antagonist which is silenced by CpG methylation in esophageal cancer | Prof. TAO Qian |
Page 90 of 262.